1,3,2-Diazaborolidine, 2-bromo-1,3-bis(methylsulfonyl)-4,5-diphenyl-,(4R,5R)- (157765-37-2)

Other Product

• 1,3,2-Diazaborolidine,2-bromo-1,3-bis[(4-fluorophenyl)sulfonyl]-4,5-diphenyl-, (4R,5R)-
• 1,3,2-Diazaborolidine,2-bromo-1,3-bis[(4-methylphenyl)sulfonyl]-4,5-diphenyl-, (4R,5R)-
• 1,3,2-Diazaborolidine,2-bromo-1,3-bis[(4-nitrophenyl)sulfonyl]-4,5-diphenyl-, (4R,5R)-
• 1,3,2-Diazaborolidine,1,3-bis[[3,5-bis(trifluoromethyl)phenyl]sulfonyl]-2-bromo-4,5-diphenyl-,(4R,5R)-
• 1,3,2-Diazaborolidine,2-bromo-1,3-bis(2-naphthalenylsulfonyl)-4,5-diphenyl-, (4R,5R)-
• 1,3,2-Diazaborolidine, 2-bromo-4,5-diphenyl-1,3-bis(phenylsulfonyl)-,(4R,5R)-
• (2R,3R,4R,5R)-2-[[(4-methoxyphenyl)-diphenyl-methoxy]methyl]-5-[6-[[(4-methoxyphenyl)-diphenyl-methyl]amino]purin-9-yl]-4-(1-piperidyl)oxolan-3-ol
• 1H-Imidazole,2,2'-(2,6-pyridinediyl)bis[4,5-dihydro-1-(2-methylbenzoyl)-4,5-diphenyl-,(4R,4'R,5R,5'R)-
• 6-Oxabicyclo[3.2.1]octan-7-one,4-(benzoyloxy)-1-[(methylsulfonyl)oxy]-3-(2-propenyl)-, (1S,3S,4R,5R)-
• 3-Piperidinecarbonitrile, 6-hydroxy-5-nitro-4,6-diphenyl-2-thioxo-,(4R,5R)-rel-, compd. with morpholine (1:1)
• 1-Cyclohexene-1-carboxylic acid,3-(1-ethylpropoxy)-4-hydroxy-5-[(methylsulfonyl)oxy]-, ethyl ester,(3R,4R,5R)-
• (3R,4R,5R)-4-(1-Ethylpropoxy)-3-hydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester
• 7-Thia-2-azabicyclo[2.2.1]heptane-5-carboxylic acid,1-methyl-3-oxo-2,4-diphenyl-, (1R,4R,5R)-rel-
• 7-Thia-2-azabicyclo[2.2.1]heptan-3-one,5-acetyl-1-methyl-2,4-diphenyl-, (1R,4R,5R)-rel-
• Isoxazolidine,3-[5-(1,1-dimethylpropyl)-2-methoxyphenyl]-4-nitro-2,5-diphenyl-,(3R,4R,5R)-rel-
• Acetonitrile,[1-[4-[(5R)-5-[[(methylsulfonyl)oxy]methyl]-2-oxo-3-oxazolidinyl]phenyl]-4-piperidinylidene]-
• 1,3,2-Diazaborolidine,2-butyl-1-ethyl-
• 1,3,2-Diazaborolidine,1-methyl-2-phenyl-
• 1,3,2-Diazaborolidine, 1,3-dimethyl-2-(1-propynyl)-
• 1,3,2-Diazaborolidine, 1-ethyl-2-phenyl-